FSD Pharma Inc.: FSD Pharma Submits a Clinical Trial Protoco

TORONTO, ON / ACCESSWIRE / May 28, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech

Related Keywords

Canada , United States , Toronto , Ontario , Canadian , Zeeshan Saeed , Andrzej Chruscinski , Nasdaq , Scientific Affairs , Pharma Inc , Strategic Investments Inc , Lucid Psycheceuticals Inc , Drug Administration , Celly Nutrition Corp , Company Annual Report On Form , Health Canada , Lucid Psycheceuticals , Celly Nutrition , Investments Inc , Canadian Securities Administrators , Annual Report , Registration Statement , Executive Co Chairman , Ihr Portfolio ,